title: BCG vaccination of young adults at risk of tuberculosis: a meaningful precaution in low-prevalence settings?
authors.forename: Lars-Olof
authors.initials: LO
authors.lastname: Larsson
authors.forename: Harald
authors.initials: H
authors.lastname: Fjällbrant
authors.forename: Olle
authors.initials: O
authors.lastname: Widström
authors.forename: Malin
authors.initials: M
authors.lastname: Ridell
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000367:Age Factors; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D006801:Humans; D015995:Prevalence; D014374:Tuberculin Test; D014376:Tuberculosis / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D055815:Young Adult
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine